Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic systemic disorder causing the development of renal and hepatic cysts and decline in renal function. It affects around 1 in 1,000 live births. Early hypertension and progressive renal failure due to massive enlargement of cysts and fibrosis are hallmarks of the disease. This article reviews recent advances in ADPKD and focuses mainly on diagnosis, management, and prediction of the course of the disease.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference57 articles.
1. Clinical practice. Autosomal dominant polycystic kidney disease.;J Grantham;N Engl J Med.,2008
2. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium;Cell.,1994
3. PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein.;T Mochizuki;Science.,1996
4. Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.;M Audrézet;Hum Mutat.,2012
5. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.;R Torra;J Am Soc Nephrol.,1996
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献